Cargando…
Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells
Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder that causes systemic accelerated aging in children. This syndrome is due to a mutation in the LMNA gene that leads to the production of a truncated and toxic form of lamin A called progerin. Because the balance between the A-type...
Autores principales: | Egesipe, Anne-Laure, Blondel, Sophie, Lo Cicero, Alessandra, Jaskowiak, Anne-Laure, Navarro, Claire, Sandre-Giovannoli, Annachiara De, Levy, Nicolas, Peschanski, Marc, Nissan, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515002/ https://www.ncbi.nlm.nih.gov/pubmed/28721276 http://dx.doi.org/10.1038/npjamd.2016.26 |
Ejemplares similares
-
Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes
por: Lo Cicero, Alessandra, et al.
Publicado: (2018) -
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
por: Harhouri, Karim, et al.
Publicado: (2018) -
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation
por: Blondel, S, et al.
Publicado: (2016) -
Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts
por: Gabriel, Diana, et al.
Publicado: (2015) -
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
por: Chojnowski, Alexandre, et al.
Publicado: (2015)